Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 20/20 | 0.69 |
| ▸ | SCN7A | Q01118 | 4/20 | 0.49 |
| ▸ | SCN5A | Q14524 | 4/20 | 0.49 |
| ▸ | SCN2B | O60939 | 1/20 | 0.47 |
| ▸ | SCN1A | P35498 | 1/20 | 0.47 |
| ▸ | SCN4A | P35499 | 1/20 | 0.47 |
| ▸ | SCN1B | Q07699 | 1/20 | 0.47 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.47 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21075302 | 0.87 | SCN9A (0.68) | SCN9ASCN5A | |
| SCHEMBL15536750 | 0.86 | SCN9A (0.73) | SCN9ASCN7ASCN5A | |
| SCHEMBL15537121 | 0.86 | SCN9A (0.73) | SCN9ASCN7ASCN5A | |
| SCHEMBL19064879 | 0.86 | SCN9A (0.64) | SCN9ASCN7ASCN5ASCN2BSCN1A | |
| SCHEMBL17428603 | 0.86 | SCN9A (0.64) | SCN9ASCN7ASCN5ASCN2BSCN1A | |
| SCHEMBL19064880 | 0.86 | SCN9A (0.64) | SCN9ASCN7ASCN5ASCN2BSCN1A | |
| SCHEMBL21075383 | 0.82 | SCN9A (0.72) | SCN9ASCN7ASCN5ASCN2BSCN1A | |
| SCHEMBL19064748 | 0.82 | SCN9A (0.59) | SCN9ASCN7ASCN5ASCN2BSCN1A | |
| SCHEMBL19064749 | 0.82 | SCN9A (0.59) | SCN9ASCN7ASCN5ASCN2BSCN1A | |
| SCHEMBL19064955 | 0.82 | SCN9A (0.59) | SCN9ASCN7ASCN5ASCN2BSCN1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3166939-B1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | GENENTECH INC (US) | 2019-06-05 | — | — | EP | disclosed |